MyGlucoCare: A Smartphone App to Help Women with Gestational Diabetes
Official title: Development and Feasibility Testing of the "MyGlucoCare" Smartphone-Based Self-Management for Personalised Support of Women With Gestational Diabetes
Run by Hong Kong Metropolitan University · NCT07372872 · Data updated 2026-11-12
This pilot test checks if the MyGlucoCare app is usable and helps women with gestational diabetes manage their blood sugar and well-being.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Hong Kong Metropolitan University Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | November 30, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT07372872 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women with GDM between 24–28 weeks gestation, aged 18 or older, who own a smartphone with internet access and can read Chinese.
✕Probably not a fit
Participants who do not engage with the app, have severe mental health issues, or have other structured GDM programs may not experience benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-arm, pre-post pilot study conducted in Hong Kong to test the feasibility, acceptability, and preliminary impact of the MyGlucoCare smartphone program for women with gestational diabetes. Participants will use the app for 8–12 weeks during pregnancy, receiving personalized education, clinician support, and access to a moderated peer group, while logging health data and completing questionnaires. Researchers will evaluate recruitment, retention, data completion, engagement, and perceived usefulness, and explore signals of improved self-management, glycemic control, activity, and stress, along with descriptive maternal/neonatal outcomes to inform a larger future trial.
Why it matters
Potential benefit: If successful, the app could support better self-management of gestational diabetes and potentially improve maternal and neonatal outcomes.
How similar studies have gone: Previous smartphone-based self-management tools for GDM have shown feasibility and willingness to participate, with mixed signals on clinical outcomes, making this pilot important for feasibility in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women diagnosed with Gestational Diabetes Mellitus (GDM) via a 75g Oral Glucose Tolerance Test (OGTT), conducted between 24 and 28 weeks of gestation (Hong Kong College of Obstetricians and Gynaecologists, 2016). * Aged 18 years or older. * Own a smartphone with reliable internet access. * Able to read and understand Chinese. Exclusion Criteria: * Pre-existing diagnosis of Type 1 or Type 2 diabetes mellitus. * Known major fetal anomaly. * Concurrent enrollment in any other structured GDM self-management intervention. * Severe mental health conditions.
Where it's running
-
Hong Kong Metropolitan University
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Bronya Luk Assistant Professor, DHSc, MN, BN
- Email: bluk@hkmu.edu.hk
- Phone: +852 39708758
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Metformin vs glyburide for blood sugar in gestational diabetes
This study tests whether metformin or glyburide better controls blood sugar in pregnant women with gestational diabetes who need oral medication.
-
Quality of life and psychological factors in women with gestational diabetes
This study tests how gestational diabetes affects quality of life and stress or anxiety in pregnant women treated at a hospital in Ludhiana.
-
Myo-Inositol for Glycemic Control in Gestational Diabetes
This study tests whether taking myo-inositol with folic acid can improve blood sugar control and reduce inflammation in pregnant people with gestational diabetes.
-
Daily kefir during mid-pregnancy to see if it helps prevent gestational diabetes
Pregnant people will drink kefir daily from mid-pregnancy to see if it improves blood sugar and insulin, reduces gestational diabetes risk, and positively affects gut bacteria.
-
Protective effect of lactation on gestational diabetes in a future pregnancy
This observational study tests whether lactation around the time of a first pregnancy is linked to a lower risk of gestational diabetes in a subsequent pregnancy for women who conceive while lactating.
-
Natural cervical ripening to delay pharmacological induction of labor
This pilot study tests whether nipple stimulation and membrane sweeping can help some pregnant people go into labor on their own without needing drugs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.